Abstract. We used microarray-based comparative genomic hybridization to explore genome-wide profiles of chromosomal aberrations in 26 samples of head and neck cancers compared to their pair-wise normal controls. The samples were obtained from Sudanese (n=11) and Norwegian (n=15) patients. The findings were correlated with clinicopathological variables. We identified the amplification of 41 common chromosomal regions (harboring 149 candidate genes) and the deletion of 22 (28 candidate genes). Predominant chromosomal alterations that were observed included high-level amplification at 1q21 (harboring the S100A gene family) and 11q22 (including several MMP family members). Regions of copy number increase was also identified at 6p21 (p21), 7p12 (EGFR), 17p13 (p53) and 19p13.2 (p19 INK4d ), while regions showing deletion included among others 3p25.2 (RAF1) and 9p21 (p15, p16). We found genes from four common biological pathways (MAPK signaling, cytokine-cytokine receptor interaction, ECM-receptor interaction and Jak-STAT signaling) to be predominantly over-represented in areas of gain and loss. The current study provides valuable information on chromosomal aberrations likely to be involved in the pathogenesis of head and neck cancers. An increased copy number of the S100A and MMP gene family members, known to be involved in invasion and metastasis, may play an important role in the development of the tumors. Hierarchical clustering of the chromosomal alterations with clinicopathological parameters showed little correlation, suggesting an occurrence of gains/losses regardless of ethnic differences and clinicopathological status between the patients from the two countries. Our findings indicate the existence of common gene-specific amplifications/deletions in these tumors, regardless of the source of the samples or attributed carcinogenic risk factors.
Introduction
Head and neck squamous cell carcinoma (HNSCC), including the oral squamous cell carcinoma (OSCC) subtype, is an aggressive disfiguring disease characterized by events of heterogeneous chromosomal/genetic alterations influencing growth, proliferation and differentiation of the cells (1) . The main etiological factors related to the development of HNSCCs involve the use of tobacco and alcohol consumption (2) (3) (4) (5) . While the incidence of HNSCCs in industrial countries seems to be related to cigarette smoking and alcohol consumption, the use of smokeless tobacco is suggested to be the main carcinogenic risk factor in developing countries. Although social habits of cigarette smoking and alcohol consumption are common in Norway, the incidence rate of HNSCCs reported in the period 1996-2001 has been rather low, affecting 6.1% of male and 2.5% of female patients (6) . Due to cultural and religious constraints, cigarette smoking and alcohol consumption are not common in Sudan and the high incidence of HNSCCs reported in that country (11.6% for males and 6.91% for females) is attributed to the extensive use of the locally produced, highly carcinogenic smokeless tobacco, locally known as toombak (7) .
Microarray-based comparative genomic hybridization (array CGH) is a powerful method that allows detection and analysis of chromosomal copy number changes (gains/losses) at a high resolution throughout the genome (8, 9) . Contrary to the conventional CGH that is limited by its resolution, array CGH can be used to capture chromosomal changes at levels of 5-10 kb of the DNA sequence, including the detection of Array CGH. The genomic microarray that was used contained 4,549 bacterial-and P1 artificial chromosome (BAC and PAC) clones representing the human genome at ~1 Mb resolution, as well as the minimal tiling-path between 1q12-q25. The microarrays were provided by the Norwegian Microarray Consortium (NMC, www.microarray.no).
Tissue samples of the tumor and normal controls were removed from the RNALater storage solution and genomic DNA was extracted using a DNeasy purification kit (Qiagen Inc, Valencia, CA, USA) according to the manufacturer's instructions. Array-CGH was performed as described previously (49). In brief, 500 ng genomic DNA purified from tumor and normal control DNA were digested with DpnII (New England Biolabs, Ipswich, MA, USA). Tumor DNA was labeled with Cy3-dCTP and normal control DNA with Cy5-dCTP (NEN Life Science Products Inc., Boston, MA, USA) by random priming. The labeled DNA samples were combined and mixed with 135 μg human Cot-1 DNA (Roche Diagnostics Corp., Indianapolis, IN, USA). Hybridization was performed using an automated hybridization station, GeneTAC/HybArray (Genomic Solutions, Ann Arbor, MI, USA) with agitation for 42 h at 37˚C. The arrays were scanned using an Agilent G2565B scanner (Agilent Technologies Inc., Santa Clara, CA, USA).
Array CGH data analysis. Images were analyzed using GenePix Pro 3.1 software (Molecular Devices Corp., Sunnyvale, CA, USA). Further data processing, including filtering and normalization, was performed as previously described using M-CGH, a MATLAB toolbox designed for the analysis of array CGH experiments (16, 17) . Detailed clone information, chromosomal regions, gene content and genes involved in various forms of cancer were accessed using the Ensembl (http://www.ensembl.org), GeneCards ® (http:// www.genecards.org) and The Cancer Genome Anatomy Project -CGAP (http://cgap.nci.nih.gov/) databases.
For the detection of chromosomal regions showing gains/ losses common for the two populations, CGH-Explorer software was used (http://www.ifi.uio.no/forskning/grupper/ bioinf/Papers/CGH). Alterations of specific chromosomal regions >0.3 and <-0.3 on log 2 scale found in a minimum of 20% of the Sudanese and Norwegian patients were considered for further investigation.
Furthermore, we investigated chromosomal alterations (gains/losses) for each population separately. Chromosomal regions that were found to be either amplified or deleted in a minimum of 18% of one population were expected not to show any alterations in the other population. We performed an analysis of the panel of all genes located in regions of chromosomal gains/losses in respect to their possible involvement in biological pathways using Kyoto Encyclopedia of Genes and Genomes -KEGG (http://www. kegg.com).
Hierarchical clustering of the chromosomal gains and losses found in the tumors examined from patients from Sudan and Norway was performed using J-Express Pro software (http://www.molmine.com/software.htm). Chromosomal alterations found in the tumors from the two countries were correlated with clinicopathological data including tumor site, age, gender, histological differentiation, tumor, lymph node, cigarette smoking and use of snuff.
Results

Clinicopathological evaluation. Samples of HNSCCs from
Norway (n=15) and Sudan (n=11) were investigated in this study (Table I) . There was a relative predominance of males for the two populations (Norway: 73%, Sudan: 64%). Although the tumors were obtained from different sites of the head and neck region in the two populations, the oral cavity was predominant among Sudanese (100%) compared to Norwegian patients [oral cavity (60%), larynx (33%) and maxillary sinus (7%)]. With regard to histological differentiation of the tumors, high differentiation (HD) was found in four (36%) of the Sudanese and five (33%) of the Norwegian patients, moderate (MD) in four (36%) Sudanese and eight (54%) Norwegian and poor (PD) in three (28%) Sudanese and two (13%) Norwegian patients. The tumor stage profile showed advanced stage (III/IV) in six (55%) of the Sudanese and six (40%) of the Norwegian samples. For Sudan, the data on the patients' habits of tobacco use/alcohol consumption showed that there were 10 (91%) non-smokers, nine (82%) non-drinkers and eight (73%) non-users of smokeless tobacco. Among the Norwegian patients, two (13%) were moderate smokers, six (40%) non-drinkers and five (33%) non-users of smokeless tobacco.
Chromosomal gains common in tumors examined from
Sudan and Norway. Array CGH was used to investigate ONCOLOGY REPORTS 20: 825-843, 2008 Table I. Clinicopathological parameters of the patients diagnosed with the OSCCs. 
M, male; F, female; H.D., histological differentiation; H, high; M, moderate; P, poor; TNM, (T) tumor; (N), lymph node; (M), metastasis; HS, heavy smoker (>20 cigarettes per day); MS, moderate; smoker (11-20 cigarettes per day); LS, light smoker (1-10 cigarettes per day); NS, non-smoker; XS, ex-smoker; HD, heavy drinker (>5 drinks per day); MD, moderate drinker (3-5 drinks per day); LD, light drinker (1-3 drinks per day); ND, non-drinker and nd, not determined.
genome-wide profiles of chromosomal aberrations in HNSCCs compared to their pair-wise controls. Fig. 1 shows a representative ratio plot for one HNSCC from Norway and one from Sudan. Frequency plots of chromosomal aberrations detected in HNSCCs from Norway and Sudan, are shown in Fig. 2A and B, respectively.
A panel of 41 regions of chromosomal gains common in the samples from the two populations were identified. These regions contained 149 candidate genes. Using KEGG analysis of the 149 genes, we detected candidate genes participating in 13 biological pathways; cell communication, MAPK signaling, calcium signaling, cytokine-cytokine receptor interaction, cell cycle, cell apoptosis, Wnt signaling, focal adhesion, ECMreceptor interaction, cell adhesion molecules, adherens junctions, gap junctions and Jak-STAT signaling. Distribution (%) of amplifications/deletions and corresponding biological pathways found in the tumors examined from Sudan and Norway are given in Table III . Four pathways were particularly predominant; MAPK signaling, cytokine-cytokine receptor interaction, ECM-receptor interaction and Jak-STAT signaling.
The distribution of common significant gains in the HNSCCs examined from Sudan and Norway is shown in (Table III and IVA) .
Genes participating in cell communication pathways were found to be amplified, including COL1A1, COL4A1, COL11A2, LMNA and NES. Of interest was the observation of COL4A1 copy number increase in 14/15 (93.3%) of Norwegian and 11/11 (100%) of Sudanese HNSCC samples (Table IVA) . We found a copy number increase of genes involved in the cell cycle regulatory pathway p21, p19 INK4d , EP300, CCND1, CCND2 and p53 (Table IVA) . Gains were also observed at the chromosomal region containing CDK10 in 3/15 (20%) of Norwegian and 4/11 (36.4%) of Sudanese samples. The amplification of chromosomal regions containing regulatory genes of apoptosis were found in samples from the two populations, particularly BAD, BCL2L1 and FADD. An increased copy number on log 2 >2 was observed in two samples from Norway (N17, N46) and a copy number on log 2 >3 was found in two samples from Norway (N48, N50) and one sample from Sudan (S50) of regions harboring the genes NTRK1, BIRC2 and BIRC3 were observed. A summary of the common copy number gains in Norway and Sudan are shown in Fig. 3A and B.
We found several altered regions on chromosome 1 in the two populations, with a copy number increase of 1p36, 1q21, 1q23 and 1q32. The TNFRSF4 gene, mapped to BAC CTB-14E10 at 1p36, was amplified in 5/15 (33.3%) and 3/11 (27.3%) of Norwegian and Sudanese patients, respectively. One of the Norwegian samples (N21) showed a copy number increase higher than two of TNFRSF4 on the log 2 scale. In the two populations, BAC RP1-148L21 at 1q21 showed a notable amplification of members of the S100A gene family. An increased copy number of a regulatory gene of the cell cycle, Mdmx and KISS-1 precursor was detected in 26.7% of the Norwegian and 27.3% of the Sudanese HNSCC samples. It was noteworthy to observe that the gene for metastasis suppressor protein 1 (MTSS1), mapped to BAC RP11-532M24 at 8p22, was amplified in 6/15 (40%) of the Norwegian and 8/11 (72.7%) of the Sudanese HNSCC samples and one Sudanese patient (S69) showed a copy number increase higher than three of this region on the log 2 scale.
Co-amplification was detected at 11q13, hosting EMS1, SHANK2 and CCND1 genes. BAC RP11-750P5 at 11q22 contained several matrix metallopeptidases (MMPs) cell-cell interaction genes, including MMP1, MMP3, MMP7, MMP8, MMP10, MMP12, MMP13 and MMP20, which were coamplified in the two populations.
Chromosomal losses common in tumors examined from Sudan and Norway. We identified 28 candidate genes that were located in deleted regions in the two populations. The distribution of common significant losses in the tumors examined from Norway and Sudan is shown in Table IVB. Table II . Distribution (%) of the clinicopathological characteristics of the patients diagnosed with the OSCCs.
11 (42) 15 (58) Gender Male, n (%) 7 (64) 11 (73) Female, n (%)
4 (36) 4 (27) Mean age 62 64
Tumor location Oral cavity, n (%) 11 (100) 9 (60) Larynx, n (%) 0 5 (33) Sinus, n (%) 0 1 (7) Tumor differentiation Poor, n (%)
6 (55) 6 (40) Smoking, n (%) 1 (10) 3 (20) Smokeless tobacco use, n (%) 3 (27) 10 (67) Alcohol use, n (%) 2 (18)
The deletion of chromosomal regions hosting genes involved in MAPK signaling included FGF5, FGF9 and RAF1 (involved in the Ras-dependant signaling pathway between the receptors and the nucleus), as well as TGFBR2. Common copy number losses in the samples from Norway and Sudan are shown in Fig. 3C . We found three genes participating in cytokine-cytokine receptor interaction were deleted, IL5RA, TGFBR2 and TNFSF11 (mapped to BAC RP11-10H6, RP11-69K20 and RP11-117I13, respectively). For the two countries, a copy number loss at 3p22 was observed in 5/15 (33.3%) of Norwegian and 3/11 (27.3%) of Sudanese HNSCCs. This region contains a gene involved in DNA repair, MHL1 (DNA mismatch repair protein). The cell cycle genes p15 INK4a and p16 INK4b mapped to BAC RP11-149I2 at 9p21, which was deleted in 4/15 (26.7%) and 3/11 (27.3%) of Norwegian and Sudanese patients, respectively.
Among the genes located in common deleted chromosomal regions, MAPK signaling, cytokine-cytokine receptor interaction and the regulation of the actin cytoskeleton represented the predominant biological pathways.
Hierarchical clustering. Hierarchical clustering of the chromosomal gains and losses found in the tumors examined from patients from Sudan and Norway and the clinicopathological data were performed (Fig. 4) . Although, there was a tendency for the majority of the tumors from each country to group tightly to each other in one of the two main subgroups, we did not find any specific correlation between chromosomal alterations and clinicopathological parameters such as age, gender, tumor stage, tumor site, differentiation status or social habits of alcohol, tobacco and snuff use. Chromosomal gains and losses that differ significantly between populations. Furthermore, we analyzed the data in search for regions of copy number gains/losses specific for each population. The results of country-specific chromosomal alterations in the HNSCCs examined from Sudan and Norway are shown in Fig. 2A and B. For Sudan, we found regions hosting 75 genes to be preferentially amplified. The genes included COL5A1, COL2A1, RASEF, MAPK4 and a large family of keratins (KRT10, KRT12, KRT20, KRT23, KRT24 and KRT25A-D). Additionally, we found chromosomal regions that were deleted only in Sudanese samples. These regions hosted 66 genes, among others several interleukins (IL22RA1, IL28RA1, IL7R, BIRC6, COL1A2, MMP19 and CDK2). For Norway, we detected preferentially amplified regions with 33 genes, of which five (15%) participated in the MAPK signaling pathway, four (12%) in the regulation of actin cytoskeleton and four (12%) as cell adhesion molecules (CAMs). Deletions of chromosomal regions specific for Norway affected 65 genes, including several interleukins (IL3, IL4, IL5, IL9 and IL13) and CD2, CD58, COL7A1, MAPK10 and CD44. Collagens, keratins and interleukins were the predominant genes found to be located in amplified or deleted regions in each population separately.
Discussion
Genome-wide analysis by array CGH was used to identify quantitative chromosomal alterations in HNSCCs from Sudan and Norway. The amplification and deletion of regions harboring in total 149 and 28 candidate genes, respectively, 
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were found as common for the samples examined from the two countries. Although the degree of copy number increase/decrease varied by ±3-4-fold on the log 2 scale between the two populations, the alterations seemed to affect the same chromosomal regions. Affected genes were involved in cell communication, MAPK signaling, cell cycle, apoptosis, Jak-STAT signaling, as well as DNA repair.
Of interest was the detection of amplification of 13q24 in 100% of the Sudanese and 93.3% of the Norwegian samples. This region contains the gene COL4A1, which is a basic structural component of all basement membranes and has previously been reported in the HNSCCs (20) (21) (22) (23) . The resulting amplification of this gene may be one of the important factors contributing to structural disintegration of the basement membrane in cells undergoing a dysplastic formation.
Several previous studies have shown overexpression or mutation of the EGFR gene in a significant number of cancers, including different subtypes of HNSCCs. The 7p12 region containing this gene was found amplified in 36.3 and 33.3% of Sudanese and Norwegian samples, respectively. Overexpression of EGFR and MYC (found to be amplified in 100% of the Sudanese and 46.7% of the Norwegian samples in our experiment), represent common genetic alterations in oralesophageal cancers (24, 25) . The genes regulate multiple biological processes, including cell proliferation, differentiation and growth. The cell cycle gene p15 INK4a , which interacts with CDK4/CDK6 and negatively regulates the proliferation of normal cells and p16 INK4b , which potentially affects TGF-ß-induced cell cycle arrest and inhibits CDK4 and CDK6, both mapped to BAC RP11-149I2 at 9p21, which was found deleted in nearly 27% of the samples from the two populations.
Of interest was the finding of the copy number increase of 1q32 harboring the MDM4 gene, which plays a key role as a ONCOLOGY REPORTS 20: 825-843, 2008 833 Table III . Distribution (%) of the chromosomal amplifications/deletions and the corresponding biological pathways. Table IV . Distribution of the common significant gains and losses in the HNSCCs examined from Sudan (n=11) and Norway (n=15).
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negative regulator of p53 (43) . Although a number of various human cancers show amplification and overexpression of MDM4, the exact mechanism of the negative regulation of p53 by the mdm4 protein and the contribution of this to tumor formation, remains uncertain (44) . We found a predominant copy number increase of the chromosomal region hosting p53, which has been previously reported as mutated and overexpressed in HNSCCs examined from Sudan and Norway (18, 19) . We detected the amplification of 1q21, harboring the calcium-binding protein genes S100A1-A14, in 72% of Sudanese and 46% of Norwegian samples. These findings are in agreement with previous studies showing potential involvement of the S100A gene family in OSCCs examined from Sudan and Norway (31, 32) . An interaction between S100A1 and -A4 has previously been studied with the suggestion that they may be involved in cancer invasion and metastasis (33, 34) . The S100A2 gene, has previously been reported as a potential marker in early-stage patients with oral cancer and was shown to interact with p53, thereby modulating its activity (35, 36) .
Loss of heterozygosity (LOH) and frequent chromosomal rearrangements at 11q in HNSCC have been previously described (37, 38) . Of interest, is the finding that the amplification of 11q13, containing among others CCND1, registered on average in 30.3% of all samples. This chromosomal region was found to be of key importance in the early events of tumor development and progression by protooncogene activation, and was recently reported to be gained in another array CGH study of HNSCCs (26) . Amplification of CCND1 has been reported in bladder, gastric, breast and pancreatic cancers, suggesting its role as a predictive biomarker (27) (28) (29) (30) .
In head and neck cancers, high-level amplification and/or overexpression of CCND1 has been suggested to enhance tumor growth, aggressive development and poor patient prognosis (13, 39, 40) . The 11q13 amplicon hosts in addition to CCND1, EMS1 and SHANK2 two important growth factors, FGF3 and FGF4. These genes seem to play an important role in driving the 11q13 amplification and show good correlation between the amplification status and overexpression (41) .
Amplification of 11q22 were found in 27% of the Sudanese and 20% of the Norwegian samples and this finding seems to be consistent with previous reports in a genome-wide analysis of HNSCCs by array CGH (42) . The region hosts two genes that function as inhibitors of apoptosis, BIRC2 and BIRC3, as well as eight members of a rich family of matrix metallopeptidases (MMPs) that play an important role in cell-cell interaction, remodeling and degradation of extra-cellular matrix (MMP1, MMP3, MMP7, MMP8, MMP10, MMP12, MMP13 and MMP20). Previous studies have shown that protelytic/enzymatic properties of MMPs are essential for a tumor's ability to initiate the degradation of ECM and to access and establish new blood and lymphatic pathways in order to invade new regions and metastasize to remote organs (45) . The status of the copy number increase of the MMPs found in our study, along with amplification of chromosomal regions hosting genes involved in cell apoptosis, such as BAD, BCL2L1, FADD, NTRK1, p53, BIRC2, BIRC3 and PDCD4, may have the potential as a predictor of invasiveness and metastatic ability of HNSCCs and thereby determining patients survival prognosis (23, (46) (47) (48) . Since MMPs are related to ECM degradation and genes for several collagens, which are important constituents of ECM, were found to be amplified in this study the possible interaction between MMPs and collagens warrants further studies.
To conclude, the results presented here provide valuable information on common chromosomal alterations possibly involved in the carcinogenesis of oral cancers. The profile of common chromosomal aberrations in the HNSCCs investigated, of which 149 genes were found located in 41 amplified regions and 28 genes in 22 deleted regions, suggests the existence of similar gene-specific alterations in the patients examined from Sudan and Norway, regardless of differences related to ethnicity and social-cultural risk factors. Hierarchical clustering of the chromosomal gains and losses found in the tumors against clinicopathological parameters showed little correlation, suggesting the occurrence of these tumors regardless of ethnic differences and clinicopathological status between the patients from the two countries.
Furthermore, cytokine-cytokine receptor interaction (calcium signaling), MAPK signaling and ECM-receptor interaction/focal adhesion/cell adhesion were found as important biological pathways involved in the pathogenesis of the cancers examined. High-level amplification of collagens, MMPs and S100A gene family members observed in the HNSCCs investigated, may provide valuable information that can be used for understanding the pathogenesis of the disease. Further studies are therefore necessary to elaborate on the role(s) of these gene family markers in HNSCCs.
